Safety And Tolerability Of Subcutaneous MANP In Difficult To Control/Resistant Hypertensive Subjects
Clinical trial NCT05247528 · COMPLETED
Trial details
- NCT number
- NCT05247528
- Sponsor
- E-Star BioTech, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-20
- Primary completion
- 2022-10-31
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.